Stocksigma LogoStocksigma Logo

Gland Pharma to Direct-Own US Subsidiary via Internal Restructuring

Gland Pharma Limited's board approved the 100% equity acquisition of step-down subsidiary Gland Pharma USA Inc. from Gland Pharma International Pte

Gland Pharma to Direct-Own US Subsidiary via Internal Restructuring

Gland Pharma Ltd 路 Outcome 路 13 Sept 2026, 9:57 pm

Gland Pharma to Direct-Own US Subsidiary via Internal Restructuring Gland Pharma Limited's board approved the 100% equity acquisition of step-down subsidiary Gland Pharma USA Inc. from Gland Pharma International Pte. Ltd for a cash consideration of USD 5,01,208 on 13th Sep'26. The transaction transitions Gland US into a direct wholly-owned subsidiary to eliminate corporate holding layers and streamline organizational structure, with expected completion by 31st Oct'26. Gland US, engaged in pharma marketing and distribution, reported nil turnover in FY26, following USD 87,342 in FY25 and USD 4,83,808 in FY24.

Original exchange filing (PDF)

More announcements from Gland Pharma Ltd

All Gland Pharma Ltd announcements